搜尋





搜尋





市場行情
/
股票
/
smmt
/

Summit Therapeutics Inc

SMMT

添加自選

13.105USD

-0.555-4.06%

收盤 07-27 16:00（美東）報價延遲15分鐘

10.39B總市值

虧損本益比TTM

Summit Therapeutics Inc

13.105

-0.555-4.06%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

SMMT 利潤表

您可以在這裡找到Summit Therapeutics Inc的年度或季度收入報告，以深入了解Summit Therapeutics Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

營業總收入

----

--0.00

----

--0.00

-100.00%0.00

-83.19%220.00K

312.28%235.00K

30.21%250.00K

35.68%251.00K

623.20%1.31M

-66.47%57.00K

-40.74%192.00K

--185.00K

--181.00K

--170.00K

--324.00K

營業收入

----

--0.00

----

--0.00

-100.00%0.00

-83.19%220.00K

312.28%235.00K

30.21%250.00K

35.68%251.00K

623.20%1.31M

-66.47%57.00K

-40.74%192.00K

--185.00K

--181.00K

--170.00K

--324.00K

營業費用

-61.21%220.50M

192.01%195.21M

241.73%224.93M

303.02%234.21M

1169.71%568.44M

56.92%66.85M

80.88%65.82M

179.97%58.11M

184.16%44.77M

153.87%42.60M

188.24%36.39M

12.91%20.76M

14.69%15.76M

-30.38%16.78M

-57.65%12.62M

-25.30%18.38M

-50.92%13.74M

15.92%24.10M

84.02%29.81M

30.75%24.61M

54.62%27.99M

81.96%20.79M

--16.20M

--18.82M

--18.10M

--11.43M

研發費用

-24.17%157.73M

158.69%132.62M

186.66%147.29M

247.51%131.10M

575.44%208.02M

66.05%51.27M

107.07%51.38M

146.19%37.72M

225.87%30.80M

212.38%30.87M

360.71%24.81M

-10.12%15.32M

4.92%9.45M

-51.92%9.88M

-76.69%5.39M

-14.51%17.05M

-62.35%9.01M

11.85%20.56M

87.94%23.11M

45.29%19.94M

76.27%23.92M

42.34%18.38M

--12.29M

--13.73M

--13.57M

--12.91M

折舊攤銷及損耗

24.32%46.00K

76.00%44.00K

90.91%42.00K

110.00%42.00K

85.00%37.00K

-7.41%25.00K

-26.67%22.00K

-37.50%20.00K

-56.52%20.00K

-70.00%27.00K

-90.16%30.00K

-89.68%32.00K

-86.10%46.00K

-71.61%90.00K

-7.01%305.00K

-8.01%310.00K

-4.61%331.00K

-5.37%317.00K

-28.38%328.00K

-15.11%337.00K

-3.34%347.00K

-0.89%335.00K

--458.00K

--397.00K

--359.00K

--338.00K

其他營業費用

----

99.71%-1.00K

100.00%0.00

99.46%-12.00K

98.65%-42.00K

68.55%-340.00K

-325.93%-4.24M

-15.03%-2.20M

-75.76%-3.11M

43.11%-1.08M

43.14%-995.00K

-54.14%-1.92M

64.99%-1.77M

---1.90M

---1.75M

---1.24M

---5.06M

營業利潤

61.21%-220.50M

-192.01%-195.21M

-241.73%-224.93M

-303.02%-234.21M

-1169.71%-568.44M

-56.92%-66.85M

-80.88%-65.82M

-179.97%-58.11M

-184.16%-44.77M

-153.87%-42.60M

-188.24%-36.39M

-14.28%-20.76M

-16.69%-15.76M

29.65%-16.78M

57.29%-12.62M

22.05%-18.16M

51.66%-13.50M

-15.78%-23.85M

-84.58%-29.55M

-25.00%-23.30M

-55.77%-27.93M

-85.54%-20.60M

---16.01M

---18.64M

---17.93M

---11.10M

淨非營業利息收入（費用）

利息收入

----

--2.38M

--2.48M

----

利息費用

----

-100.00%0.00

-99.69%9.00K

-9.81%2.46M

23.34%3.10M

-62.52%3.12M

-26.97%2.90M

2131.15%2.72M

878.60%2.52M

5378.29%8.33M

4797.53%3.97M

--122.00K

28.50%257.00K

462.96%152.00K

--81.00K

----

--200.00K

--27.00K

----

出售證券收益

54.42%4.30M

46.98%5.79M

30.19%5.75M

-47.19%2.42M

19.19%2.78M

93.32%3.94M

1542.75%4.42M

1064.00%4.58M

-35.11%2.33M

-24.22%2.04M

106.55%269.00K

---475.00K

--3.60M

--2.69M

-92.46%-4.11M

----

-4053.70%-2.13M

----

--54.00K

----

特殊收入（費用）

----

--0.00

100.00%0.00

----

--0.00

----

---15.01M

100.00%0.00

--0.00

---520.91M

---8.47M

----

-100.00%0.00

100.00%0.00

----

--480.00K

---859.00K

----

-固定資產出售收益

--500.00K

----

其他非經營性收入（費用）

----

--5.79M

-100.00%0.00

----

---53.00K

----

100.96%1.00K

----

100.00%0.00

-100.00%0.00

-101.14%-104.00K

98.52%-64.00K

99.87%-5.00K

-54.33%417.00K

685.74%9.15M

-3725.66%-4.32M

-686.42%-3.82M

269.70%913.00K

312.80%1.16M

86.83%-113.00K

-326.32%-486.00K

-116.50%-538.00K

---547.00K

---858.00K

---114.00K

--3.26M

稅前利潤

61.87%-215.70M

-201.09%-189.42M

-256.91%-219.17M

-313.99%-231.79M

-834.38%-565.71M

-44.01%-62.91M

-67.12%-61.41M

-160.02%-55.99M

-312.48%-60.54M

91.95%-43.69M

-83.52%-36.74M

4.76%-21.53M

16.51%-14.68M

-2251.01%-542.92M

34.58%-20.02M

3.44%-22.61M

38.57%-17.58M

-9.10%-23.09M

-91.00%-30.61M

-15.01%-23.41M

-58.59%-28.62M

-169.88%-21.17M

---16.02M

---20.36M

---18.05M

---7.84M

所得稅

----

-15.17%-205.00K

199.62%264.00K

-507.69%-159.00K

60.70%-213.00K

77.55%-178.00K

78.35%-265.00K

104.81%39.00K

68.04%-542.00K

77.39%-793.00K

67.92%-1.22M

80.73%-810.00K

53.90%-1.70M

-35.81%-3.51M

-45.89%-3.81M

-51.88%-4.20M

-115.27%-3.68M

---2.58M

---2.62M

---2.77M

---1.71M

除稅後利潤

61.87%-215.70M

-201.09%-189.42M

-258.11%-219.17M

-312.05%-231.79M

-836.84%-565.71M

-44.72%-62.91M

-67.37%-61.20M

-164.50%-56.25M

-310.31%-60.38M

91.98%-43.47M

-90.17%-36.57M

0.55%-21.27M

12.25%-14.72M

-2434.82%-542.38M

29.04%-19.23M

-9.11%-21.39M

31.31%-16.77M

-22.35%-21.40M

-101.60%-27.10M

-10.46%-19.60M

-59.80%-24.42M

-185.10%-17.49M

---13.44M

---17.74M

---15.28M

---6.13M

持續經營利潤

61.87%-215.70M

-201.09%-189.42M

-258.11%-219.17M

-312.05%-231.79M

-836.84%-565.71M

-44.72%-62.91M

-67.37%-61.20M

-164.50%-56.25M

-310.31%-60.38M

91.98%-43.47M

-90.17%-36.57M

0.55%-21.27M

12.25%-14.72M

-2434.82%-542.38M

29.04%-19.23M

-9.11%-21.39M

31.31%-16.77M

-22.35%-21.40M

-101.60%-27.10M

-10.46%-19.60M

-59.80%-24.42M

-185.10%-17.49M

---13.44M

---17.74M

---15.28M

---6.13M

歸属于母公司的淨利潤

61.87%-215.70M

-201.09%-189.42M

-258.11%-219.17M

-312.05%-231.79M

-836.84%-565.71M

-44.72%-62.91M

-67.37%-61.20M

-164.50%-56.25M

-310.31%-60.38M

91.98%-43.47M

-90.17%-36.57M

0.55%-21.27M

12.25%-14.72M

-2434.82%-542.38M

29.04%-19.23M

-9.11%-21.39M

31.31%-16.77M

-22.35%-21.40M

-101.60%-27.10M

-10.46%-19.60M

-59.80%-24.42M

-185.10%-17.49M

---13.44M

---17.74M

---15.28M

---6.13M

歸屬普通股東的淨利潤

61.87%-215.70M

-201.09%-189.42M

-258.11%-219.17M

-312.05%-231.79M

-836.84%-565.71M

-44.72%-62.91M

-67.37%-61.20M

-164.50%-56.25M

-310.31%-60.38M

91.98%-43.47M

-90.17%-36.57M

0.55%-21.27M

12.25%-14.72M

-2434.82%-542.38M

29.04%-19.23M

-9.11%-21.39M

31.31%-16.77M

-22.35%-21.40M

-101.60%-27.10M

-10.46%-19.60M

-59.80%-24.42M

-185.10%-17.49M

---13.44M

---17.74M

---15.28M

---6.13M

基本每股收益

63.61%-0.28

-186.57%-0.24

-244.57%-0.29

-302.78%-0.31

-793.06%-0.76

-37.59%-0.09

-59.16%-0.08

-153.97%-0.08

-304.46%-0.09

95.68%-0.06

47.59%-0.05

78.82%-0.03

87.47%-0.02

-557.36%-1.43

64.08%-0.10

28.43%-0.14

37.52%-0.17

-3.32%-0.22

-57.39%-0.28

23.80%-0.20

-18.52%-0.27

-131.38%-0.21

---0.18

---0.26

---0.23

---0.09

稀釋每股收益

63.61%-0.28

-186.57%-0.24

-244.57%-0.29

-302.78%-0.31

-793.06%-0.76

-37.59%-0.09

-59.16%-0.08

-153.97%-0.08

-304.46%-0.09

95.68%-0.06

47.59%-0.05

78.82%-0.03

87.47%-0.02

-557.36%-1.43

64.08%-0.10

28.43%-0.14

37.52%-0.17

-3.32%-0.22

-57.39%-0.28

23.80%-0.20

-18.52%-0.27

-131.38%-0.21

---0.18

---0.26

---0.23

---0.09

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Summit Therapeutics Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 SMMT 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Summit Therapeutics Inc 全年的淨利潤是多少？



Summit Therapeutics Inc 2025 財年淨利潤為 -1.08B。

Summit Therapeutics Inc 上一季度的淨利潤是多少？



Summit Therapeutics Inc 最近一個季度的淨利潤為 -215.70M。

Summit Therapeutics Inc 年度營業利潤是多少？



Summit Therapeutics Inc 2025 財年的營業利潤為 -1.09B。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。